Literature DB >> 15956842

Extrahepatic manifestations in patients with chronic hepatitis C virus infection.

Manuel Ramos-Casals1, Josep Font.   

Abstract

PURPOSE OF REVIEW: Chronic hepatitis C virus infection often has autoimmune clinical and analytic features. This review analyzes recent data on the close association of chronic hepatitis C virus infection with autoimmune and lymphoproliferative processes. RECENT
FINDINGS: Hepatitis C virus infection has been associated with both organ-specific (thyroiditis, diabetes) and systemic autoimmune diseases. Experimental, virologic, and clinical evidence has demonstrated a close association between hepatitis C virus infection and Sjögren syndrome, with hepatitis C virus-associated Sjögren syndrome being indistinguishable in most cases from the primary form. With respect to rheumatoid arthritis, patients with hepatitis C virus-related polyarthritis and positive rheumatoid factor may fulfill the classification criteria for rheumatoid arthritis. Hepatitis C virus has also been associated with an atypical presentation of antiphospholipid syndrome, as well as with the development of sarcoidosis. A higher prevalence of hematologic processes in patients with hepatitis C virus infection has recently been reported, including cytopenias and lymphoproliferative disorders. Recent data are available on the use of new immunosuppressive and biologic agents (mainly mycophenolate mofetil, anti-tumor necrosis factor agents, and rituximab) in patients with hepatitis C virus infection and autoimmune or lymphoproliferative manifestations.
SUMMARY: There is increasing evidence of a close association of hepatitis C virus infection with autoimmune and hematologic processes. The sialotropism of hepatitis C virus may explain the close association with Sjögren syndrome, and its lymphotropism links the virus to cryoglobulinemia, autoimmune cytopenias, and lymphoma. The substantial overlap between cryoglobulinemic features and the classification criteria for some systemic autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis, and polyarteritis nodosa) make the differentiation between mimicking and coexistence difficult.

Entities:  

Mesh:

Year:  2005        PMID: 15956842     DOI: 10.1097/01.bor.0000166386.62851.49

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  16 in total

1.  Hepatitis C virus infection and its rheumatologic implications.

Authors:  Zeynel A Sayiner; Uzma Haque; Mohammad U Malik; Ahmet Gurakar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-05

2.  Interferon-alpha Induced Sarcoidosis with Cutaneous Involvement along the Lines of Venous Drainage.

Authors:  Young Bok Lee; Jae In Lee; Hyun Jeong Park; Baik Kee Cho; Shin Taek Oh
Journal:  Ann Dermatol       Date:  2011-05-27       Impact factor: 1.444

3.  Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward.

Authors:  Ayman El Garf; Bassel El Zorkany; Rasha Gheith; Hala Sheba; Geilan Abdel Moneim; Kamal El Garf
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

4.  Anti-SSB/La antibody is negatively associated with HLA-DR2 in chronic hepatitis C infection.

Authors:  Chien-Sheng Wu; Chung-Yi Hu; Ping-Ning Hsu
Journal:  Clin Rheumatol       Date:  2007-11-09       Impact factor: 2.980

Review 5.  Lessons from diseases mimicking Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Josep Font
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 6.  Autoimmunity and infection in Sjögren's syndrome.

Authors:  Ann Igoe; R Hal Scofield
Journal:  Curr Opin Rheumatol       Date:  2013-07       Impact factor: 5.006

Review 7.  Immunopathologic differences of Sjögren's syndrome versus sicca syndrome in HCV and HIV infection.

Authors:  Claudio Vitali
Journal:  Arthritis Res Ther       Date:  2011-08-19       Impact factor: 5.156

8.  Linkage of type I interferon activity and TNF-alpha levels in serum with sarcoidosis manifestations and ancestry.

Authors:  Nadera J Sweiss; Wei Zhang; Beverly S Franek; Silvia N Kariuki; David R Moller; Karen C Patterson; Peggy Bennett; Lakshmi R Girijala; Vaisak Nair; Robert P Baughman; Joe G N Garcia; Timothy B Niewold
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

9.  How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.

Authors:  Pilar Brito-Zerón; Hoda Gheitasi; Soledad Retamozo; Albert Bové; María Londoño; Jose-Maria Sánchez-Tapias; Miguel Caballero; Belchin Kostov; Xavier Forns; Srini V Kaveri; Manuel Ramos-Casals
Journal:  Arthritis Res Ther       Date:  2015-09-10       Impact factor: 5.156

10.  Life-Threatening Cryoglobulinemic Patients With Hepatitis C: Clinical Description and Outcome of 279 Patients.

Authors:  Soledad Retamozo; Cándido Díaz-Lagares; Xavier Bosch; Albert Bové; Pilar Brito-Zerón; Maria-Eugenia Gómez; Jordi Yagüe; Xavier Forns; Maria C Cid; Manuel Ramos-Casals
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.